Intra-rater Reliability and Agreement Between Two Dual Task Tests; WBB and Gait Test.

Sponsor
Aalborg University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04700605
Collaborator
(none)
30
1
2.3
12.9

Study Details

Study Description

Brief Summary

Agreement and intra-rater reliability between static balance test using Nintendo Wii Balance Board and gait test under dual-task conditions in community-dwelling older adults.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Dual task balance test

Detailed Description

Participants:

Investigators aim to recruit a minimum of 30 participants aged 65 years or above through convenience sampling at an senior activity centre in the Municipality of Aalborg. Participants inclusion critiria is age about 65, the ability to stand for 30 seconds unaided and the ability to walk 8 meters. Exclusion critiria is severe cognitive impairment (e.g., dementia).

Procedure:

Each participant will undergo two testdays separated by approximately two weeks. Both testdays have the same number and order of tests and are placed approximately the same time of the day. At the first testday descriptive information for each participant is collected.

Measuring device:

The Nintendo Wii Balance Board (Nintendo, Kyoto, Japan) is a small portable force plate measuring sway ellipse area and sway speed.

Analysis:

Will include intra-rater reliability for each test and agreement between the two. Calculations of balance/gait costs will be made to unify the unit and to compare the two tests to each other. Results shown by intraclass correlation coeffients and Bland Altman plots.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
30 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Intra-rater Reliability and Agreement Between Static Balance Test Using Nintendo Wii Balance Board and Gait Test Under Dual Task Conditions in Community-dwelling Older Adults.
Actual Study Start Date :
Oct 27, 2020
Anticipated Primary Completion Date :
Jan 6, 2021
Anticipated Study Completion Date :
Jan 6, 2021

Outcome Measures

Primary Outcome Measures

  1. Intra-rater reliability for the gait test and the WBB test. [Through study completion, app. 8 months.]

    Comparing the dual task costs for each test between test and retest. Assessments through intraclass correlation coefficient and reportings in accordance with Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

Secondary Outcome Measures

  1. Agreement between the gait test and the WBB test as dual task measurements. [Through study completion, app. 8 months.]

    Comparing the dual task costs between the gait test and the Wii Balance Board test. Data assessment through Bland Altman plots and reportings in accordance with Guidelines for Reporting Reliability and Agreement Studies (GRRAS).

  2. Descriptive data. [Through study completion, app. 8 months.]

    Qustionnairies consisting of Tilburg Frailty Indicator, Vulnerable Elders Survey 13, Short Falls Efficacy Scale, previous falls, medications and Orientations-Memory-Concentrations test. Data assessment through histograms and Shapiro Wilk tests and reported by means and standard deviations, medians and interquartile ranges, and numbers and percentages.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Minimum 65 years old.

  • Community dwelling

Exclusion Criteria:
  • Unable to stand unsupported for 30 seconds

  • Unable to walk 8 meters unsupported

Contacts and Locations

Locations

Site City State Country Postal Code
1 Liselund Aktivitets Center Vodskov Aalborg Denmark 9310

Sponsors and Collaborators

  • Aalborg University Hospital

Investigators

  • Principal Investigator: Martin Eriksen, Aalborg University Hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Martin Eriksen, Medical student, Aalborg University Hospital
ClinicalTrials.gov Identifier:
NCT04700605
Other Study ID Numbers:
  • 2020-096
First Posted:
Jan 8, 2021
Last Update Posted:
Jan 8, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Jan 8, 2021